Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.
Company Details
- Employees
- 33
- Address
- 47 Thorndike St, Suite B1-1, Cambridge,ma 02141,united States
- Phone
- (617)714-0360
- in****@****ptx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- leaptx.com
- HQ
- Cambridge, MA
Leap Therapeutics Questions
Leap Therapeutics's helpline number is (617)714-0360
Leap Therapeutics's website is leaptx.com
Leap Therapeutics's LinkedIn profile is https://www.linkedin.com/company/leap-therapeutics
Leap Therapeutics has
33 employees.
View email and phone details for 33
employees at Leap Therapeutics.
Leap Therapeutics's industry is
Biotechnology Research
Leap Therapeutics's top competitors are
Torl Biotherapeutics Llc,
Century Therapeutics, Inc,
Seaport Therapeutics,
Nvelop Therapeutics,
D3 Bio,
Nurix Therapeutics,
Oculis,
Clade Therapeutics,
Climb Bio,
Bluerock Therapeutics.
Leap Therapeutics's support email address is info@leaptx.com
Leap Therapeutics's categories are Biotechnology Research
